These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 30047189)

  • 41. Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
    Manara M; Caporali R; Favalli EG; Grosso V; Atzeni F; Sarzi Puttini P; Gorla R; Bazzani C; Fusaro E; Pellerito R; Rocchetta PA; Sinigaglia L
    Clin Exp Rheumatol; 2017; 35(5):804-809. PubMed ID: 28770712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study.
    Buchbinder R; Van Doornum S; Staples M; Lassere M; March L
    BMC Musculoskelet Disord; 2015 Oct; 16():309. PubMed ID: 26481039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis.
    Queiro R; Lorenzo A; Tejón P; Pardo E; Coto P; Ballina J
    Int J Rheum Dis; 2019 Feb; 22(2):269-274. PubMed ID: 30398011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.
    Puyraimond-Zemmour D; Etcheto A; Fautrel B; Balanescu A; de Wit M; Heiberg T; Otsa K; Kvien TK; Dougados M; Gossec L
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1504-1509. PubMed ID: 27998030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study.
    Christensen IE; Lillegraven S; Mielnik P; Bakland G; Loli L; Sexton J; Uhlig T; Kvien TK; Provan SA
    Ann Rheum Dis; 2022 Mar; 81(3):398-401. PubMed ID: 34625404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
    Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
    Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.
    Batko B; Urbański K; Świerkot J; Wiland P; Raciborski F; Jędrzejewski M; Koziej M; Cześnikiewicz-Guzik M; Guzik TJ; Stajszczyk M
    Clin Rheumatol; 2019 Sep; 38(9):2473-2481. PubMed ID: 31076943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry.
    Reddy SM; Anandarajah AP; Fisher MC; Mease PJ; Greenberg JD; Kremer JM; Reed G; Chen R; Messing S; Kaukeinen K; Ritchlin CT
    J Rheumatol; 2010 Dec; 37(12):2566-72. PubMed ID: 20843908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Kerola AM; Rollefstad S; Kazemi A; Wibetoe G; Sexton J; Mars N; Kauppi M; Kvien TK; Haavardsholm EA; Semb AG
    Scand J Rheumatol; 2023 Jan; 52(1):42-50. PubMed ID: 35014920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark.
    Secher AEP; Granath F; Glintborg B; Rom A; Hetland ML; Hellgren K
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36328400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study.
    Jin Y; Chen SK; Liu J; Kim SC
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1248-1256. PubMed ID: 32754989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
    Solomon DH; Love TJ; Canning C; Schneeweiss S
    Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
    Lindström Egholm C; Krogh NS; Pincus T; Dreyer L; Ellingsen T; Glintborg B; Kowalski MR; Lorenzen T; Madsen OR; Nordin H; Rasmussen C; Hetland ML
    J Rheumatol; 2015 Oct; 42(10):1781-5. PubMed ID: 26233511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis.
    Favarato MH; Mease P; Gonçalves CR; Gonçalves Saad C; Sampaio-Barros PD; Goldenstein-Schainberg C
    Clin Exp Rheumatol; 2014; 32(2):182-7. PubMed ID: 24480317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity.
    Treharne GJ; Douglas KM; Iwaszko J; Panoulas VF; Hale ED; Mitton DL; Piper H; Erb N; Kitas GD
    Musculoskeletal Care; 2007 Dec; 5(4):175-90. PubMed ID: 17623274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.
    Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK
    Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
    Michelsen B; Uhlig T; Sexton J; van der Heijde D; Hammer HB; Kristianslund EK; Wierød A; Bakland G; Rødevand E; Krøll F; Loge JH; Haugeberg G; Kvien TK
    Ann Rheum Dis; 2018 Sep; 77(9):1290-1294. PubMed ID: 29875096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.